Share

August 13, 2013; 81 (7) Article

An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke

David M. Kent, Robin Ruthazer, Christian Weimar, Jean-Louis Mas, Joaquín Serena, Shunichi Homma, Emanuele Di Angelantonio, Marco R. Di Tullio, Jennifer S. Lutz, Mitchell S.V. Elkind, John Griffith, Cheryl Jaigobin, Heinrich P. Mattle, Patrik Michel, Marie-Louise Mono, Krassen Nedeltchev, Federica Papetti, David E. Thaler
First published July 17, 2013, DOI: https://doi.org/10.1212/WNL.0b013e3182a08d59
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
6173

Share

Article Information

vol. 81 no. 7 619-625
DOI: 
https://doi.org/10.1212/WNL.0b013e3182a08d59
PubMed: 
23864310
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received December 12, 2012
  • Accepted in final form April 29, 2013
  • First Published July 17, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. David M. Kent, MD, CM, MSc,
    2. Robin Ruthazer, MPH,
    3. Christian Weimar, MD,
    4. Jean-Louis Mas, MD,
    5. Joaquín Serena, MD, PhD,
    6. Shunichi Homma, MD,
    7. Emanuele Di Angelantonio, MD, MSc,
    8. Marco R. Di Tullio, MD,
    9. Jennifer S. Lutz, MS,
    10. Mitchell S.V. Elkind, MD, MS,
    11. John Griffith, PhD,
    12. Cheryl Jaigobin, MD, MSc,
    13. Heinrich P. Mattle, MD,
    14. Patrik Michel, MD,
    15. Marie-Louise Mono, MD,
    16. Krassen Nedeltchev, MD,
    17. Federica Papetti, MD and
    18. David E. Thaler, MD, PhD
  1. David M. Kent, MD, CM, MSc,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. WL Gore Associates

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1)National Institute of Health (NIH), R21 NS079826, Principal Investigator, 2012 to 2014 (2) National Institute of Health (NIH), R01 NS062153, Principal Investigator, 2009 to 2014 (3)Patient Centered Outcomes Research Institute (PCORI) 1IP2PI000722, Principal Investigator, 2012 to 2014

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Robin Ruthazer, MPH,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH/NINDS R01 NS062153 The Risk of Paradoxical Embolism (RoPE) Study [PI=Kent] My role: Statistician/Programmer 03/06/09-02/28/14

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Christian Weimar, MD,
    4. Scientific Advisory Boards:

    1. (1) Bayer Schering (2) Bristol-Myers Squib (3) Sanofi Aventis

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) Sanofi Aventis, travel and speaker honoraria (2) Arbeitsgemeinschaft Neurologische Intensivmedizin, funding for travel (3) Deutsche Gesellschaft für Neurologie, funding for travel (4) Biogen Idec, funding for travel (5) Teva, funding for travel (6) Boehringer Ingelheim, funding for travel

    Editorial Boards:

    1. (1) Cerebrovascular Diseases, editorial board member, 2008-ongoing (2) Stroke News, editorial office 2006- ongoing

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Consultant, University hospital Essen

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. (1) Sanofi Aventis (2) Boehringer Ingelheim

    Other activities:

    1. participation in clinical trials by (1) Brainsgate, (2) D-Pharm (3) PhotoThera (4) Portola (5) Pierre Fabre

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) Johnson & Johnson

    Research Support, Government Entities:

    1. (1) German Research Council, 2010-ongoing, WE 2858/3-1 (2) TeBiKom.Ruhr, 2012-ongoing, 005-GW02-067E

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Jean-Louis Mas, MD,
    5. Scientific Advisory Boards:

    1. (1) Astra-Zeneca (2) Boehringer-Ingelheim (3) BMS (4) Daiichi-Sankyo (5) Sanofi Aventis

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. 1) Boehringer-Ingelheim, honoraria, 2) Sanofi Aventis, honoraria, 3) Servier, honoraria

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) French Ministry of Health, 1 grant, coordination of a randomized clinical trial, ongoing, (2) INSERM Institut National Scientifique Et de la Recherche Medicale, financing a Stroke Research Unit, ongoing

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Joaquín Serena, MD, PhD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Shunichi Homma, MD,
    7. Scientific Advisory Boards:

    1. St Judes - Medical Consultant Pfizer - Pharmaceutical Consultant/Advisory Bd Tekeda - Pharmaceutical Consultant/Advisory Bd BMS - Pharmaceutical Consultant/Advisory Bd

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH WARCEF Study, NIH-NINDS, U01 NS043975

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Emanuele Di Angelantonio, MD, MSc,
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Marco R. Di Tullio, MD,
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH/NINDS R01 NS36286-11 PI Years:2005-2012

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. Jennifer S. Lutz, MS,
    10. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  10. Mitchell S.V. Elkind, MD, MS,
    11. Scientific Advisory Boards:

    1. (1) Jarvik Heart, Clinical Events Committee member, adjudicating events in clinical trial of artificial heart (2008-present); (2) Biogen IDEC, scientific advisory board, stroke trial design

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1) Neurology, Resident and Fellow Section editor, published by American Academy of Neurology (2007-present)

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Columbia University

    Consultancies:

    1. (1) BMS-Pfizer Partnership, consultant regarding antithrombotics for stroke

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) diaDexus, Inc: funding for biomarker research; (2) BMS-Sanofi Pharmaceutical Partnership: funding for biomarker research

    Research Support, Government Entities:

    1. (1) NIH/NINDS P50 NS049060, Project PI, 2004-2013;(2) NIH/NINDS R37 NS029993, Co-PI, 2008-2013; (3) NIH/NINDS 1R25 NS070697, PI, 2010-2015

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) American Heart Association Founders Affiliate Board of Directors)(2008-present); (2) American Heart Association NY City Board of Directors (2011-present)

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. (1) GSK, Avandia and stroke litigation, 2009-2011;(2) Organon/Merck, NuvaRing and stroke litigation, 2009-present;(3) Novartis, aliskiren and stroke litigation, 2013-present

  11. John Griffith, PhD,
    12. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Northeastern University, Bouve College Associate Dean of Research

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) Boston Public Health Commission. Biostatistician, 2011- 2013 (2) NIH, P50HL105185, Biostatistician, 2010-2015 (3) NIH, R01NS062153, Biostatistician, 2009-2014 (4) NIH, R01MH096707, Biostatistician, 2012-2015

    Research Support, Academic Entities:

    1. Tufts Medical Center, Biostatistician -2012

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  12. Cheryl Jaigobin, MD, MSc,
    13. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Honoria at speaking engagements sponsored by Boeringer- Ingelheim and Sanofi Aventis June 2008, June 2009

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  13. Heinrich P. Mattle, MD,
    14. Scientific Advisory Boards:

    1. Servier, St. Jude Medical

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Servier, Sanofi, Bayer, Biogen, Böhringer-Ingelheim, Merck, MSD, Teva, St. Jude Medical, Novartis, Pfizer

    Editorial Boards:

    1. Stroke, International Journal of Stroke, Swiss Medical Weekly, Practical Neurology

    Patents:

    1. NONE

    Publishing Royalties:

    1. Neurologie, Kurzlehrbuch Neurologie, Neurology, Fundamentals of Neurology, DGN Leitlinien, all Thieme Publisher, Stuttgart

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Servier, Sanofi, Bayer, Biogen, Genzyme, Merck, MSD, Pfizer, Teva, AGA Medical, Novartis, Pfizer

    Speakers' Bureaus:

    1. Servier, Sanofi, Bayer, Biogen, Merck, Teva, St. Jude Medical, Novartis, Böhringer-Ingelheim

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Servier, Sanofi, Bayer, Biogen, Merck, Teva, St. Jude Medical, Novartis, Pfizer

    Research Support, Government Entities:

    1. Swiss Science Foundation

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Swiss Heart Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  14. Patrik Michel, MD,
    15. Scientific Advisory Boards:

    1. Bayer, Pfizer

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Bayer, Boehringer-Ingelheim

    Editorial Boards:

    1. International Journal of Stroke.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Pierre-Fabre

    Speakers' Bureaus:

    1. Boehringer-Ingelheim, Bayer

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Lundbeck

    Research Support, Government Entities:

    1. Swiss National Science Foundation

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Swiss Cardiology Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  15. Marie-Louise Mono, MD,
    16. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  16. Krassen Nedeltchev, MD,
    17. Scientific Advisory Boards:

    1. Served on a scientific advisory board for Bayer (Schweiz) AG, Pfizer, Boehringer-Ingelheim, Teva Pharmaceuticals, Genzyme

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Consultancies for “Innovative Technologies-Invatec” in 2007.

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Sponsor/Funding source: The Swiss National Research Foundation, Grant Nr 32003B_120522; 3 years

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Swiss Heart Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  17. Federica Papetti, MD and
    18. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  18. David E. Thaler, MD, PhD
    19. Scientific Advisory Boards:

    1. Lantheus Medical Imaging, DSMB

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. St Jude Medical (AGA Medical); WL Gore Associates

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NINDS, Risk of Paradoxical Embolism (RoPE) Study, co-PI

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Institute for Clinical Research and Health Policy Studies (D.M.K., R.R., J.S.L., J.G.) and Department of Neurology (D.M.K., D.E.T.), Tufts Medical Center/Tufts University School of Medicine, Boston, MA; Department of Neurology (C.W.), University of Duisburg-Essen, Germany; Department of Neurology (J.-L.M.), Hôpital Sainte-Anne, Paris-Descartes University, France; Department of Neurology (J.S.), Hospital Universitari Doctor Josep Trueta Institut d'Investigació Biomèdica de Girona, Spain; Division of Cardiology (S.H., M.R.D.) and Departments of Neurology (M.S.V.E.) and Epidemiology (M.S.V.E.), Columbia University, New York, NY; Department of Public Health and Primary Care (E.D.), Cambridge University, UK; Department of Neurology (C.J.), University of Toronto, Canada; Department of Neurology (H.P.M., M.-L.M.), Inselspital, University of Bern; Centre Hospitalier Universitaire de Lausanne (P.M.); Department of Neurology (K.N.), Triemli Municipal Hospital, Switzerland; and Department of Cardiology (F.P.), Sapienza University of Rome, Italy.
  1. Correspondence to Dr. Kent: Dkent1{at}tuftsmedicalcenter.org

Article usage

Article usage: July 2013 to November 2023

AbstractFullPdfSource
Jul 2013398067Highwire
Aug 2013256373225Highwire
Sep 20136043676Highwire
Oct 20133965069Highwire
Nov 20132643034Highwire
Dec 20131512329Highwire
Jan 20141461636Highwire
Feb 20141841338Highwire
Mar 20142381834Highwire
Apr 20141713559Highwire
May 20141492054Highwire
Jun 20141051739Highwire
Jul 2014822222Highwire
Aug 20141252225Highwire
Sep 2014841715Highwire
Oct 20149477Highwire
Nov 20141001513Highwire
Dec 20148799Highwire
Jan 2015701820Highwire
Jan 201506338pmc
Feb 2015722018Highwire
Feb 201506131pmc
Mar 20151081615Highwire
Mar 201507043pmc
Apr 20155698Highwire
Apr 201507638pmc
May 20157759Highwire
May 2015011043pmc
Jun 201569116Highwire
Jun 2015011433pmc
Jul 201592914Highwire
Jul 2015012037pmc
Aug 201517375Highwire
Aug 2015014338pmc
Sep 2015171207Highwire
Sep 2015017964pmc
Oct 2015164876Highwire
Oct 2015019369pmc
Nov 2015150966Highwire
Nov 2015017256pmc
Dec 20151731049Highwire
Dec 2015013943pmc
Jan 2016163958Highwire
Jan 2016017354pmc
Feb 2016125928Highwire
Feb 2016020349pmc
Mar 2016141449Highwire
Mar 2016022874pmc
Apr 2016122108Highwire
Apr 2016021350pmc
May 201680812Highwire
May 2016027777pmc
Jun 201656910Highwire
Jun 2016024266pmc
Jul 20168043Highwire
Jul 2016027686pmc
Aug 2016131117Highwire
Aug 2016026269pmc
Sep 20161541319Highwire
Sep 20160422116pmc
Oct 201616397Highwire
Oct 20160355117pmc
Nov 20161101110Highwire
Nov 20160300100pmc
Dec 201656514Highwire
Dec 2016024953pmc
Jan 20176943Highwire
Jan 2017032459pmc
Feb 201784178Highwire
Feb 2017028165pmc
Mar 201781109Highwire
Mar 2017025666pmc
Apr 2017901213Highwire
Apr 201766175215pmc
May 201781911Highwire
May 201762191220pmc
Jun 20177256Highwire
Jun 201761180198pmc
Jul 20176235Highwire
Jul 201741161191pmc
Aug 2017731010Highwire
Aug 201760166204pmc
Sep 20171131518Highwire
Sep 201788261287pmc
Oct 2017991614Highwire
Oct 2017129317366pmc
Nov 20171111212Highwire
Nov 2017120308364pmc
Dec 201714853Highwire
Jan 20181741414Highwire
Feb 201812699Highwire
Mar 20181841110Highwire
Apr 201815367Highwire
Apr 201864226251pmc
May 20181831613Highwire
Jun 201815393Highwire
Jun 201866242288pmc
Jul 201815353Highwire
Aug 20181841913Highwire
Aug 201861237276pmc
Sep 2018155137Highwire
Oct 2018196813Highwire
Nov 201820365Highwire
Dec 2018166119Highwire
Jan 201919397Highwire
Feb 201919283Highwire
Mar 2019217109Highwire
Apr 201917297Highwire
May 2019184178Highwire
Jun 20191791010Highwire
Jul 201922193Highwire
Aug 2019162119Highwire
Sep 201915064Highwire
Oct 201912921Highwire
Nov 201917178Highwire
Dec 201912322Highwire
Jan 202013386Highwire
Feb 2020180115Highwire
Mar 2020132103Highwire
Apr 20201391111Highwire
May 202012554Highwire
Jun 202016354Highwire
Jul 2020221113Highwire
Aug 202095107Highwire
Sep 2020133153Highwire
Oct 2020114159Highwire
Nov 20201161211Highwire
Dec 2020305179Highwire
Jan 2021119104Highwire
Feb 2021111103Highwire
Mar 202117074Highwire
Apr 2021124127Highwire
May 2021151147Highwire
Jun 202113653Highwire
Jul 2021135169Highwire
Aug 202114895Highwire
Sep 20211311910Highwire
Oct 2021192114Highwire
Nov 2021137125Highwire
Dec 202119665Highwire
Jan 2022156158Highwire
Feb 2022162115Highwire
Mar 202222284Highwire
Apr 202221693Highwire
May 2022185148Highwire
Jun 20221981214Highwire
Jul 202212696Highwire
Aug 2022220147Highwire
Sep 2022270219Highwire
Oct 202219755Highwire
Nov 202223066Highwire
Dec 20222071510Highwire
Jan 202322184Highwire
Feb 2023153144Highwire
Mar 2023207117Highwire
Apr 20231781511Highwire
May 2023189136Highwire
Jun 2023124126Highwire
Jul 2023114129Highwire
Aug 20231731711Highwire
Sep 2023233108Highwire
Oct 2023239112Highwire
Nov 202318887Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me

Recommended articles